| Freda C Thomas, CRNA | |
|
1444 Peterman Dr, Alexandria, LA 71301-3432 | |
| (318) 442-5399 | |
| (318) 442-1586 |
| Full Name | Freda C Thomas |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 18 Years |
| Location | 1444 Peterman Dr, Alexandria, Louisiana |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578592622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | APO4935 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Matthews Medical Center Llc | 6406845247 | 56 |
| Providence Anesthesiology Associates Pa | 3971566761 | 251 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487626933 PECOS PAC ID: 1153231907 Enrollment ID: O20031126000588 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Novant Health Thomasville Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033160205 PECOS PAC ID: 5890605224 Enrollment ID: O20031222000916 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Carolina Anesthesia Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699723791 PECOS PAC ID: 1456251057 Enrollment ID: O20040115000938 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Medical Park Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003867516 PECOS PAC ID: 4880595958 Enrollment ID: O20040120000968 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | The Presbyterian Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053365817 PECOS PAC ID: 1153231907 Enrollment ID: O20040223001121 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Forsyth Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104548874 PECOS PAC ID: 9537071790 Enrollment ID: O20040405001702 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Novant Health Rowan Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508931544 PECOS PAC ID: 3375452519 Enrollment ID: O20040422001655 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Providence Anesthesiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396739884 PECOS PAC ID: 3971566761 Enrollment ID: O20041111000930 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Novant Health Matthews Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184782419 PECOS PAC ID: 6406845247 Enrollment ID: O20051114000445 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Presbyterian Sameday Surgery Center At Ballantyne Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1215061049 PECOS PAC ID: 4587759949 Enrollment ID: O20070928000739 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Presbyterian Sameday Surgery Center At Huntersville Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1063641801 PECOS PAC ID: 8426197971 Enrollment ID: O20100521000450 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Carolina Regional Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891072609 PECOS PAC ID: 5496921769 Enrollment ID: O20120109000406 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Brunswick Community Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669725198 PECOS PAC ID: 9335150895 Enrollment ID: O20130903000403 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Novant Health Kernersville Outpatient Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1750892659 PECOS PAC ID: 3870858525 Enrollment ID: O20180530000007 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Novant Health Mint Hill Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063910404 PECOS PAC ID: 8123374394 Enrollment ID: O20181018000540 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Novant Health Clemmons Outpatient Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1528521887 PECOS PAC ID: 6103154778 Enrollment ID: O20190820003091 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Entity Name | Novant Health Ballantyne Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760190607 PECOS PAC ID: 4880065143 Enrollment ID: O20230518003163 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Freda C Thomas, CRNA Po Box 5887, Alexandria, LA 71307-5887 Ph: (318) 442-5399 | Freda C Thomas, CRNA 1444 Peterman Dr, Alexandria, LA 71301-3432 Ph: (318) 442-5399 |
News Archive
"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.
The aging of the population and the increasing prevalence of chronic diseases pose challenges to the development and application of clinical practice guidelines (CPGs), according to background information in the article. In 1999, 48 percent of Medicare beneficiaries aged 65 years or older had at least 3 chronic medical conditions and 21 percent had 5 or more.
House Republicans sent new details to the Internal Revenue Service as part of an ongoing challenge to AARP's not-for-profit tax status, following the group's leading role in pushing for enactment of the 2010 federal healthcare overhaul.
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
› Verified 1 days ago
Elizabeth A Cole, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1444 Peterman Dr, Alexandria, LA 71301 Phone: 318-442-5399 Fax: 318-442-1586 | |
Clinton D Sellers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 211 4th St # 30135, Alexandria, LA 71301 Phone: 318-448-4440 Fax: 318-473-4340 | |
Jeffery E Thomas, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 211 4th St, Alexandria, LA 71301 Phone: 318-769-3000 | |
Todd C Antony, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 211 4th St, Alexandria, LA 71301 Phone: 318-473-3000 | |
Donna K Moreau, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1444 Peterman Dr, Alexandria, LA 71301 Phone: 318-442-5399 Fax: 318-442-1586 | |
Rene Dejean, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1444 Peterman Dr, Alexandria, LA 71301 Phone: 318-442-5399 Fax: 318-442-1586 | |
Matthew J Meynard, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1444 Peterman Dr, Alexandria, LA 71301 Phone: 318-442-5399 Fax: 318-442-1586 |